BASEL MEDICAL GROUP LTD (BMGL) Stock Price, Forecast & Analysis
USA - NASDAQ:BMGL - VGG0864B1031 - Common Stock
BMGL Key Statistics, Chart & Performance
The current stock price of BMGL is 1.438 USD. In the past month the price decreased by -10.68%.
BMGL Latest News, Press Relases and Analysis
BMGL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.47 | 99.63B | ||
| CI | THE CIGNA GROUP | 9.14 | 69.29B | ||
| LH | LABCORP HOLDINGS INC | 15.85 | 20.83B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.26 | 19.93B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.18 | 19.91B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 13.11 | 14.23B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.85B | ||
| HIMS | HIMS & HERS HEALTH INC | 76.72 | 9.88B | ||
| DVA | DAVITA INC | 13.13 | 8.66B | ||
| CHE | CHEMED CORP | 19.95 | 6.40B | ||
| RDNT | RADNET INC | 217.03 | 6.01B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 32.04 | 5.79B |
Related stock screener links
About BMGL
Company Profile
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. The company employs 36 full-time employees The company went IPO on 2025-02-25. Ltd. The company provides a wide spectrum of general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Its orthopedic treatments and surgery include non-surgical treatments, such as medications, injections, splinting and physiotherapy, and surgical orthopedic procedures, including minimally invasive treatments for complex surgeries. Its rehabilitative therapy provides in-house physiotherapy treatments, including post-surgery rehabilitation, as well as sports therapy. Its neurosurgical care covers treatments involving spinal and brain conditions, from headaches and brain tumors to spinal issues, aneurysms and strokes. The company also specializes in diagnostic imaging and outpatient care.
Company Info
BASEL MEDICAL GROUP LTD
600 North Bridge Road, #12-02/03, Parkview Square
Singapore SG
Employees: 36
Phone: 6562919188
BASEL MEDICAL GROUP LTD / BMGL FAQ
What does BMGL do?
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. The company employs 36 full-time employees The company went IPO on 2025-02-25. Ltd. The company provides a wide spectrum of general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Its orthopedic treatments and surgery include non-surgical treatments, such as medications, injections, splinting and physiotherapy, and surgical orthopedic procedures, including minimally invasive treatments for complex surgeries. Its rehabilitative therapy provides in-house physiotherapy treatments, including post-surgery rehabilitation, as well as sports therapy. Its neurosurgical care covers treatments involving spinal and brain conditions, from headaches and brain tumors to spinal issues, aneurysms and strokes. The company also specializes in diagnostic imaging and outpatient care.
What is the stock price of BASEL MEDICAL GROUP LTD today?
The current stock price of BMGL is 1.438 USD. The price decreased by -0.83% in the last trading session.
Does BASEL MEDICAL GROUP LTD pay dividends?
BMGL does not pay a dividend.
What is the ChartMill rating of BASEL MEDICAL GROUP LTD stock?
BMGL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of BMGL stock?
BASEL MEDICAL GROUP LTD (BMGL) operates in the Health Care sector and the Health Care Providers & Services industry.
BMGL Technical Analysis
BMGL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BMGL. BMGL has only an average score on both its financial health and profitability.
BMGL Financial Highlights
Over the last trailing twelve months BMGL reported a non-GAAP Earnings per Share(EPS) of 0.07. The EPS decreased by -43.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.64% | ||
| ROA | 11.76% | ||
| ROE | 24.18% | ||
| Debt/Equity | 0.55 |